These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32864229)

  • 21. [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].
    Silber S
    Herz; 2010 Dec; 35(8):558-64. PubMed ID: 21107514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.
    Somma KA; Bhatt DL; Fonarow GC; Cannon CP; Cox M; Laskey W; Peacock WF; Hernandez AF; Peterson ED; Schwamm L; Saxon LA
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):654-61. PubMed ID: 22949493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: A systematic review and network meta-analysis.
    Saito T; Fujisaki T; Aikawa T; Kampaktsis PN; Malik A; Briasoulis A; Takagi H; Wiley J; Slipczuk L; Kuno T
    Int J Cardiol; 2023 Oct; 389():131157. PubMed ID: 37433404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between medication adherence and cardiovascular outcomes among acute coronary syndrome patients.
    Chinwong S; Doungsong K; Channaina P; Phrommintikul A; Chinwong D
    Res Social Adm Pharm; 2021 Sep; 17(9):1631-1635. PubMed ID: 33455883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to a Tertiary Care Academic Center in a Developing Country.
    Irawati S; Dharma S; Taxis K; Nguyen T; Nursyarofah N; Wilffert B; Hak E
    Glob Heart; 2020 Feb; 15(1):8. PubMed ID: 32489781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of ST-segment elevation myocardial infarction as clinical presentation of acute coronary syndrome.
    Kurihara O; Takano M; Kakuta T; Soeda T; Crea F; Adriaenssens T; Nef HM; Boeder NF; Yamamoto E; Kim HO; Russo M; McNulty I; Araki M; Nakajima A; Lee H; Mizuno K; Jang I-
    J Thromb Thrombolysis; 2021 May; 51(4):1026-1035. PubMed ID: 32955695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
    Kong G; Chin YH; Chong B; Goh RSJ; Lim OZH; Ng CH; Muthiah M; Foo R; Vernon ST; Loh PH; Chan MY; Chew NWS; Figtree GA
    Int J Cardiol; 2023 Jan; 371():432-440. PubMed ID: 36179904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical compliance to evidence-based clinical guidelines on secondary prevention of coronary heart disease in a hospital from Lima, Peru: a retrospective study.
    Castañeda-Amado Z; Calixto-Aguilar L; Loza Munarriz C; Medina Palomino FA
    Medwave; 2017 Jun; 17(5):e6989. PubMed ID: 28665919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and statin eligibility of patients under 50 with ST-elevation myocardial infarction.
    Haq A; Walser-Kuntz E; Gamam A; Albers A; Bae A; Benson G; Miedema MD
    Clin Cardiol; 2024 Feb; 47(2):e24231. PubMed ID: 38362951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction.
    Miedema MD; Garberich RF; Schnaidt LJ; Peterson E; Strauss C; Sharkey S; Knickelbine T; Newell MC; Henry TD
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28404560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of ST-segment elevation myocardial infarction, non-ST-segment myocardial infarction, and unstable angina: results from a Southwest Chinese Registry.
    Li SY; Zhou MG; Ye T; Cheng LC; Zhu F; Cui CY; Zhang YM; Cai L
    Rev Cardiovasc Med; 2021 Mar; 22(1):239-245. PubMed ID: 33792268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia.
    Livori AC; Ademi Z; Ilomäki J; Pol D; Morton JI; Bell JS
    Eur J Prev Cardiol; 2024 Mar; 31(5):580-588. PubMed ID: 37987181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of Management Strategies With Class I Recommendations Among Patients Hospitalized With ST-Segment Elevation Myocardial Infarction in China.
    Hao Y; Zhao D; Liu J; Liu J; Yang N; Huo Y; Fonarow GC; Ge J; Morgan L; Ma C; Han Y; Smith SC;
    JAMA Cardiol; 2022 May; 7(5):484-491. PubMed ID: 35293976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the management of acute myocardial infarction patients and their outcomes at the Nairobi Hospital from January 2007 to June 2009.
    Kimeu R; Kariuki C
    Cardiovasc J Afr; 2016; 27(4):218-221. PubMed ID: 27841909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F; Bataineh W; Jarab A
    Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.